Nephropathy - DiabetesontheNet

Impact of a new foot care intervention programme in two haemodialysis units in Nottingham, UK

Orphan heel syndrome: a vascular perspective

Breaking news in cardiovascular outcome trials; empagliflozin and stroke; and glycaemic variability in type 1 diabetes

SEARCH uncovers significantly higher rates of nephropathy in young people with type 2 diabetes

Letter from Novo Nordisk Ltd

Reduction of albuminuria in type 1 diabetes does not mean reduction in cardio-renal risk

Obesity and kidney disease: Hidden consequences of the epidemic

High-risk foot and the effect of deteriorating renal function and dialysis in people with diabetes

Could non-physician clinical care have a role in the UK?

The Steno-2 study comes of age

Utility of antidiabetes medications in chronic kidney disease: A review

Oral hypoglycaemic agents in renal impairment: Is the situation any clearer?

EMPA-REG Renal: Are we there yet?

Keeping abreast of the latest diabetes research: Glycaemic control, hypoglycaemia, combination therapy and inpatient care

When should we start renin–angiotensin system blockade in type 2 diabetes?

Q&A: Chemical pathology

Unit 2 – Comorbidities and complications: Diabetic nephropathy: Diagnosis, screening and management

Hyperkalaemia in chronic kidney disease: New treatment for an old problem